Piramal Pharma discloses ESG rating under SEBI norms
Piramal Pharma discloses ESG rating as per SEBI regulations. This filing is part of mandatory corporate governance norms under Regulation 30. No financial impact is indicated. ESG ratings may influence long-term investor sentiment.
📊 STOCKS: $PPL | 🏢 SECTOR: Pharma | #LOWIMPACT #ESG
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.